Sector
PharmaceuticalsOpen
₹0.8Prev. Close
₹0.78Turnover(Lac.)
₹0.3Day's High
₹0.81Day's Low
₹0.7552 Week's High
₹052 Week's Low
₹0Book Value
₹17.21Face Value
₹10Mkt Cap (₹ Cr.)
0.66P/E
0EPS
0Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2012 | Mar-2011 | Mar-2010 | Mar-2009 |
|---|---|---|---|---|
Equity Capital | 8.2 | 8.2 | 8.2 | 8.2 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 10.36 | 10.54 | 11.13 | 32.01 |
Net Worth | 18.56 | 18.74 | 19.33 | 40.21 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2012 | Mar-2011 |
|---|---|---|
Revenue | 0 | 0.04 |
yoy growth (%) | -100 | |
Raw materials | 0 | -0.07 |
As % of sales | 0 | 168.76 |
Employee costs | -0.01 | -0.12 |
| Y/e 31 Mar( In .Cr) | Mar-2012 | Mar-2011 |
|---|---|---|
Profit before tax | -0.17 | -0.59 |
Depreciation | -0.06 | -0.06 |
Tax paid | 0 | 0 |
Working capital | 0.07 | |
Other operating items |
| Y/e 31 Mar | Mar-2012 | Mar-2011 |
|---|---|---|
Growth matrix (%) | ||
Revenue growth | -100 | |
Op profit growth | -78.11 | |
EBIT growth | -70.28 | |
Net profit growth | -70.06 |
| Particulars (Rupees in Crores.) | Mar-2016 | Mar-2015 | Mar-2014 | Mar-2013 | Mar-2012 |
|---|---|---|---|---|---|
Gross Sales | 0 | 0 | 0 | 0 | 0 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 0 | 0 | 0 | 0 | 0 |
Other Operating Income | 0.01 | 0.01 | 0 | 0 | 0 |
Other Income | 0 | 0 | 0 | 0 | 0 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,705.55 | 95.71 | 4,09,218.58 | 753.53 | 0.94 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,600.65 | 79.35 | 1,75,226.52 | 667 | 0.45 | 2,536 | 561.08 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,741.9 | 63.7 | 1,26,637.21 | 551 | 0.16 | 2,567 | 224.34 |
Cipla Ltd CIPLA | 1,554.2 | 24.3 | 1,25,540.69 | 1,303.13 | 1.03 | 4,501.66 | 397.39 |
Dr Reddys Laboratories Ltd DRREDDY | 1,270.85 | 15.39 | 1,06,062.83 | 2,961.2 | 0.63 | 7,788.7 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
K O Isaac
Director
G Subramanian
Director
V M Sankaran Nampoothiri
No 1 Wallers Lane 1st Floor,
Room 3 Mataji Complex Mount Rd,
Tamil Nadu - 600002
Tel: -
Website: http://www.ablbiotechnologies.com
Email: -
Subramanian Building,
1ST Floor No 1, Club House Road,
Chennai - 600002
Tel: 91-44-28462700
Website: www.cameoindia.com
Email: investor@cameoindia.com
Summary
ABL Bio Technologies Limited (ABL) is an India-based biotechnology company. The Company operates in three segments: formulation, research and development and the Docosahexaenoic acid (DHA) project. Th...
Read More
Reports by ABL Bio-Technologies Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.